On the downside, GSK's COVID-19 therapy Xevudy (sotrovimab) saw a slump in demand, with sales falling to £500 million from £1.3 billion in the first quarter of 2022, and GSK is expecting the ...

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...

Breakthrough Adjuvant AB-801 Secures“Bioprocessing Excellence in Taiwan” HonorTAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE) ...

GSK’s fourth-quarter Vaccine sales declined 12% due to lower sales of its RSV vaccine Arexvy and shingles vaccine, Shingrix. Arexvy generated £158 million during the quarter, down 69% year ...

Between being a radio show host, a lead singer in a touring band, and an avid horseback rider, TV personality Faith Martin is living her best life. There's little downtime in Martin's active day ...

The global varicella vaccines market is set for consistent growth, with revenue expected to reach USD 3,258.6 million in 2024 and expand at a CAGR of 2.4% through 2034, ultimately reaching USD 4,115.4 ...

GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal Foreseeing similar difficulties in rolling out these pay-out-of-pocket vaccines, GSK recently also ...

The adult vaccines division continues to gain momentum with Shingrix (Herpes Zoster Vaccine ... Managing Director of GlaxoSmithKline Pharmaceuticals Limited, said, “Our strong third-quarter ...

GlaxoSmithKline Pharmaceuticals Ltd (GSK) on Friday announced its financial results for the third quarter ended December 31, 2024. According to the company’s exchange filing, it demonstrates ...

GlaxoSmithKline Pharma has been benefitting from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Strong demand for its vaccine for shingles, Shingrix, has ...

During this conference where the launch of the "Shingrix" vaccine was announced, Engineer Hassan Fahmi General Manager of GSK Egypt, spoke about the importance of introducing the "Shingrix ...

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the BSE.